Day Werts - Comment

Document ID: FDA-2009-N-0592-0011
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 22 2010, at 10:18 AM Eastern Standard Time
Date Posted: January 25 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: December 29 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: March 1 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a812a2
View Document:  View as format xml

This is comment on Proposed Rule

Informed Consent Elements

View Comment

Re: The proposed amendment to patient informed consent It seems to me that unless any of the 18 personal identifiers are included in the data contained on the clinical trial registry, the data submitted are no longer "human" and therefore this addition to the consent is unnecessary and superfluous. Moreover, it adds to the already stiltifying nonsense that you keep adding to consents. I'm a professional in the cancer business and am responsible for managing clinical trials. I can barely understand a 20page consent now. How 'bout considering the patient who is anxious and frightened of their diagnosis and treatment. Does anyone really believe they understand the consent? How 'bout seeing what you can do to reduce the size of these documents rather than adding to them.

Related Comments

    View All
Total: 63
Methodist Healthcare System IRB - Comment
Public Submission    Posted: 01/07/2010     ID: FDA-2009-N-0592-0006

Mar 01,2010 11:59 PM ET
Brigette White - Comment
Public Submission    Posted: 01/08/2010     ID: FDA-2009-N-0592-0008

Mar 01,2010 11:59 PM ET
Anonymous - Comment
Public Submission    Posted: 01/19/2010     ID: FDA-2009-N-0592-0010

Mar 01,2010 11:59 PM ET
Day Werts - Comment
Public Submission    Posted: 01/25/2010     ID: FDA-2009-N-0592-0011

Mar 01,2010 11:59 PM ET
Quintin Loden Whitaker - Comment
Public Submission    Posted: 01/28/2010     ID: FDA-2009-N-0592-0013

Mar 01,2010 11:59 PM ET